- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-27-0006183

Tasmine Pharmaceutical Private Limited
About Tasmine Pharmaceutical Private Limited
Data last updated:
Tasmine Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2021PTC382344. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Md Iqubal Ahmad and Sabiya Tasneem.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C – 196 Gali No – 11 Near Kadir Mashjid Shastri Park, Delhi, India – 110053.
Tasmine Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-27-0006183).
Company details
Recognitions & Rankings of Tasmine Pharmaceutical
Contact details
Tasmine Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 196 Gali No – 11 Near Kadir Mashjid Shastri Park, Delhi, India – 110053
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tasmine Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Tasmine Pharmaceutical Private Limited
FY 2022 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2021-22 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Tasmine Pharmaceutical Private Limited, buy the company report.
Board of directors of Tasmine Pharmaceutical Private Limited
Tasmine Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Md Iqubal Ahmad | Director | 16 Jun 2021 | 5 Years 4 Months | Current |
| Sabiya Tasneem | Director | 16 Jun 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Tasmine Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tasmine Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Tasmine Pharmaceutical Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Tasmine Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Tasmine Pharmaceutical Private Limited, buy the company report.
Recent activity
Tasmine Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Md Iqubal Ahmad was appointed as Director on 16 Jun 2021.
Frequently asked questions
Tasmine Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 June 2021 (5+ years old) and is registered under CIN U51909DL2021PTC382344.
Tasmine Pharmaceutical has 2 current directors:
- Md Iqubal Ahmad - Director
- Sabiya Tasneem - Director
The latest financial statements of Tasmine Pharmaceutical on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2022 are in the company report.
No. Tasmine Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Tasmine Pharmaceutical is U51909DL2021PTC382344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tasmine Pharmaceutical was incorporated on 16 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Md Iqubal Ahmad was appointed as Director on 16 Jun 2021. Sabiya Tasneem was appointed as Director on 16 Jun 2021.
Yes, Tasmine Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-27-0006183).
The registered office of Tasmine Pharmaceutical is at C – 196 Gali No – 11 Near Kadir Mashjid Shastri Park, Delhi, India – 110053.
Tasmine Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

